Precigen (STU:I5X) Inventories, Raw Materials & Components: €0.29 Mil (As of Mar. 2026)


STU:I5X Precigen Inc STU:I5X
58 GF Score
Price €4.64
GF Value €5.15
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Precigen Inventories, Raw Materials & Components?

Precigen STU:I5X -4.53% 58 Inventories, Raw Materials & Components is €0.29 Mil as of Mar. 2026. GuruFocus rates STU:I5X with a GF Score™ of 58/100 and a GF Value™ of €5.15 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Precigen's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €0.29 Mil.

Precigen's quarterly raw materials increased from Sep. 2025 (€0.00 Mil) to Dec. 2025 (€0.12 Mil) and increased from Dec. 2025 (€0.12 Mil) to Mar. 2026 (€0.29 Mil).

Precigen's annual raw materials stayed the same from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) but then increased from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.12 Mil).

Precigen Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Precigen's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen Inventories, Raw Materials & Components Chart

Precigen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.00 0.00 0.00 0.12

Precigen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.12 0.29
STU:I5X
58GF Score
Precigen Inc STU:I5X
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precigen Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0.29 Mil mean?
Precigen (STU:I5X) has a Inventories, Raw Materials & Components of €0.29 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Precigen and its competitors.
Is Precigen's Inventories, Raw Materials & Components too high?
Precigen's current Inventories, Raw Materials & Components is €0.29 Mil. Overall, Precigen has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precigen's Inventories, Raw Materials & Components compare to KARD and SLBT?
Precigen's Inventories, Raw Materials & Components of €0.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Precigen and its competitors. Precigen's current Inventories, Raw Materials & Components is €0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precigen stock overvalued right now?
Based on GuruFocus' analysis, Precigen (STU:I5X) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.15, compared to a current price of €4.64 — trading 9.9% below its estimated fair value. The current Inventories, Raw Materials & Components is €0.29 Mil. Precigen's overall GF Score™ is 58/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Precigen (STU:I5X), the current Inventories, Raw Materials & Components is €0.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precigen (STU:I5X) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of €4.64 is trading 9.9% below its estimated GF Value™ of €5.15. GuruFocus considers Precigen to be Modestly Undervalued.

Key valuation signals for STU:I5X:

  • Inventories, Raw Materials & Components: €0.29 Mil
  • GF Value™: €5.15 vs. price of €4.64 (9.9% below fair value)
  • GF Score™: 58/100 with 10 warning signs

No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precigen Business Description

Other Exchanges PGEN:USA
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
58GF Score

Get the complete analysis for STU:I5X

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.64
Price
€5.15
GF Value